Vildagliptin, sold under the brand name Galvus and others, is an oral anti-hyperglycemic agent (anti-diabetic drug) of the dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs.

Vildagliptin is a new oral antidiabetic agent that enhances pancreatic islet cell responsiveness to glucose. An extensive clinical program involving approximately 22,000 patients and 7000 …

The active substance in Galvus, vildagliptin, is a dipeptidyl-peptidase-4 (DPP-4) inhibitor. It works by blocking the breakdown of ‘incretin’ hormones in the body. These hormones are released …

Vildagliptin is a once-daily dipeptidyl peptidase 4 (DPP-4) inhibitor used in the management of type 2 diabetes mellitus. Vildagliptin (LAF237) is an orally active antihyperglycemic agent that …

Vildagliptin is a new oral antihyperglycemic (anti-diabetic) tablet from the new dipeptidyl peptidase-4 (DPP-4) inhibitor class. The medication works by preventing DPP-4 from …

Vildagliptin is an oral medication used to manage type 2 diabetes. It belongs to the drug family of dipeptidyl peptidase-4 (DPP-4) inhibitors, which play a crucial role in regulating blood sugar …

Vildagliptin is a selective and potent dipeptidyl peptidase-4 inhibitor that improves glycemic control by inhibiting the degradation of both endogenous glucagon-like peptide-1 and glucose …

2024年8月7日 · Vildagliptin 50 mg is a valuable medication for managing type 2 diabetes mellitus. Its benefits include improved glycemic control, weight neutrality, low risk of hypoglycemia, …

Vildagliptin (Galvus ®, LAF 237, Novartis) is an inhibitor of dipeptidyl peptidase 4 (DPP-4) that has been developed for the treatment of type 2 diabetes. The drug was approved for use in …

2025年2月4日 · Vildaglipt 50mg Tablet is a medicine used to treat type 2 diabetes mellitus. It is used together with a healthy diet and regular exercise to control blood sugar levels. This helps …